Xi Liu
Founder chez BEIJING STRONG BIOTECHNOLOGIES,INC.
Fortune : 179 M $ au 31/03/2024
Profil
Xi Liu founded Beijing Strong Biotechnologies, Inc. in 2001, where he is working as General Manager & Director from 2011.
Dr. Liu also currently works at Fuzhou Maixin Biotech Co., Ltd., as Director from 2020.
Dr. Liu received his graduate degree in 1982 from Harbin Engineering University and doctorate degree in 1988 from Institute of Automation Chinese Academy of Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 50 260 257 ( 19,76% ) | 134 M $ | 31/03/2024 | |
| 30/06/2023 | 16 753 419 ( 5,01% ) | 45 M $ | 31/03/2024 |
Postes actifs de Xi Liu
| Sociétés | Poste | Début |
|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Founder | 29/03/2001 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 30/09/2020 |
Formation de Xi Liu
| Harbin Engineering University | Graduate Degree |
| Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
